BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 23453682)

  • 1. First report of transperineal polyethylene glycol hydrogel spacer use to curtail rectal radiation dose after permanent iodine-125 prostate brachytherapy.
    Beydoun N; Bucci JA; Chin YS; Malouf D; Enari E; Painter SD
    Brachytherapy; 2013; 12(4):368-74. PubMed ID: 23453682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyethylene glycol hydrogel rectal spacer implantation in patients with prostate cancer undergoing combination high-dose-rate brachytherapy and external beam radiotherapy.
    Yeh J; Lehrich B; Tran C; Mesa A; Baghdassarian R; Yoshida J; Torrey R; Gazzaniga M; Weinberg A; Chalfin S; Ravera J; Tokita K
    Brachytherapy; 2016; 15(3):283-287. PubMed ID: 26853354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rectal spacing, prostate coverage, and periprocedural outcomes after hydrogel spacer injection during low-dose-rate brachytherapy implantation.
    Kahn J; Dahman B; McLaughlin C; Kapoor P; Kapoor R; Harris E; Sharma M; Schutzer M; Moghanaki D
    Brachytherapy; 2020; 19(2):228-233. PubMed ID: 32085930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dosimetric study of polyethylene glycol hydrogel in 200 prostate cancer patients treated with high-dose rate brachytherapy±intensity modulated radiation therapy.
    Strom TJ; Wilder RB; Fernandez DC; Mellon EA; Saini AS; Hunt DC; Pow-Sang JM; Spiess PE; Sexton WJ; Poch MA; Biagioli MC
    Radiother Oncol; 2014 Apr; 111(1):126-31. PubMed ID: 24746567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Placement of an absorbable rectal hydrogel spacer in patients undergoing low-dose-rate brachytherapy with palladium-103.
    Taggar AS; Charas T; Cohen GN; Boonyawan K; Kollmeier M; McBride S; Mathur N; Damato AL; Zelefsky MJ
    Brachytherapy; 2018; 17(2):251-258. PubMed ID: 29241706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application technique: placement of a prostate-rectum spacer in men undergoing prostate radiation therapy.
    Hatiboglu G; Pinkawa M; Vallée JP; Hadaschik B; Hohenfellner M
    BJU Int; 2012 Dec; 110(11 Pt B):E647-52. PubMed ID: 22788857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyethylene glycol-based hydrogel rectal spacers for prostate brachytherapy: a systematic review with a focus on technique.
    Vaggers S; Rai BP; Chedgy ECP; de la Taille A; Somani BK
    World J Urol; 2021 Jun; 39(6):1769-1780. PubMed ID: 32840655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of prostate brachytherapy techniques with polyethylene glycol-based hydrogel spacers: A systematic review.
    Afkhami Ardekani M; Ghaffari H
    Brachytherapy; 2020; 19(1):13-23. PubMed ID: 31542390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rectal-wall dose dependence on postplan timing after permanent-seed prostate brachytherapy.
    Taussky D; Yeung I; Williams T; Pearson S; McLean M; Pond G; Crook J
    Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):358-63. PubMed ID: 16563654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transperineal injection of hyaluronic acid in anterior perirectal fat to decrease rectal toxicity from radiation delivered with intensity modulated brachytherapy or EBRT for prostate cancer patients.
    Prada PJ; Fernández J; Martinez AA; de la Rúa A; Gonzalez JM; Fernandez JM; Juan G
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):95-102. PubMed ID: 17707267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved rectal dosimetry with the use of SpaceOAR during high-dose-rate brachytherapy.
    Wu SY; Boreta L; Wu A; Cheung JP; Cunha JAM; Shinohara K; Chang AJ
    Brachytherapy; 2018; 17(2):259-264. PubMed ID: 29203149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose-rate brachytherapy for prostate cancer in a previously radiated patient with polyethylene glycol hydrogel spacing to reduce rectal dose: case report and review of the literature.
    Nguyen PL; Devlin PM; Beard CJ; Orio PF; O'Leary MP; Wolfsberger LD; O'Farrell DA; Sweeney CM; Hadaschik BA; Hohenfellner M; Hatiboglu G
    Brachytherapy; 2013; 12(1):77-83. PubMed ID: 22543116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrogel Spacer Prospective Multicenter Randomized Controlled Pivotal Trial: Dosimetric and Clinical Effects of Perirectal Spacer Application in Men Undergoing Prostate Image Guided Intensity Modulated Radiation Therapy.
    Mariados N; Sylvester J; Shah D; Karsh L; Hudes R; Beyer D; Kurtzman S; Bogart J; Hsi RA; Kos M; Ellis R; Logsdon M; Zimberg S; Forsythe K; Zhang H; Soffen E; Francke P; Mantz C; Rossi P; DeWeese T; Hamstra DA; Bosch W; Gay H; Michalski J
    Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):971-977. PubMed ID: 26054865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of a rectal spacer with low-dose-rate brachytherapy for treatment of prostate cancer in previously irradiated patients: Initial experience and short-term results.
    Mahal BA; Ziehr DR; Hyatt AS; Neubauer-Sugar EH; O'Farrell DA; O'Leary MP; Steele GS; Niedermayr TR; Beard CJ; Martin NE; Orio PF; D'Amico AV; Devlin PM; Nguyen PL
    Brachytherapy; 2014; 13(5):442-9. PubMed ID: 24880584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rectal toxicity profile after transperineal interstitial permanent prostate brachytherapy: use of a comprehensive toxicity scoring system and identification of rectal dosimetric toxicity predictors.
    Shah JN; Ennis RD
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):817-24. PubMed ID: 16297567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary and Rectal Toxicity Profiles After Permanent Iodine-125 Implant Brachytherapy in Japanese Men: Nationwide J-POPS Multi-institutional Prospective Cohort Study.
    Ohashi T; Yorozu A; Saito S; Tanaka N; Katayama N; Kojima S; Maruo S; Kikuchi T; Dokiya T; Fukushima M; Yamanaka H
    Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):141-9. PubMed ID: 26279031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postimplant rectal dosimetry is not dependent on 103Pd or 125I seed activity.
    Merrick GS; Sylvester J; Grimm P; Allen ZA; Butler WM; Reed JL; Khanjian J
    Brachytherapy; 2011; 10(1):35-43. PubMed ID: 20153264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Difference in rectal dosimetry between pre-plan and post-implant analysis in transperineal interstitial brachytherapy for prostate cancer.
    Ishiyama H; Kitano M; Satoh T; Niibe Y; Uemae M; Fujita T; Baba S; Hayakawa K
    Radiother Oncol; 2006 Feb; 78(2):194-8. PubMed ID: 16414135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate seed implantation using 3D-computer assisted intraoperative planning vs. a standard look-up nomogram: Improved target conformality with reduction in urethral and rectal wall dose.
    Raben A; Chen H; Grebler A; Geltzeiler J; Geltzeiler M; Keselman I; Litvin S; Sim S; Hanlon A; Yang J
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1631-8. PubMed ID: 15590195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of obesity on rectal dosimetry after permanent prostate brachytherapy.
    Patil N; Crook J; Saibishkumar EP; Aneja M; Borg J; Pond G; Ma C
    Brachytherapy; 2009; 8(2):218-222. PubMed ID: 19230790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.